Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.1.29NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.4.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.4.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.47NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.47NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FK.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FK.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FK.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.26.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.26.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.26.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DS.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DS.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DS.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.5.1.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.1.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.6.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.6.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.6.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.2.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19563.7Singapore
BN.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.11.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.11.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.11.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.14NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.14NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.4.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.4.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.4.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GM.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-1878.2US
GM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GM.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-1981.37China
BQ.1.1.20NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BQ.1.1.20NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.20NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BQ.1.26NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used